Allosteric modulators targeting CNS muscarinic receptors
Authors:
Open Access
- 1 July 2018
- journal article
- review article
- Published by Elsevier in Neuropharmacology
- Vol. 136, 427-437
Abstract
No abstract availableKeywords
This publication has 119 references indexed in Scilit:
- Structure and dynamics of the M3 muscarinic acetylcholine receptorNature, 2012
- Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonistNature, 2012
- The allosteric vestibule of a seven transmembrane helical receptor controls G-protein couplingNature Communications, 2012
- Muscarinic Acetylcholine Receptor Subtypes as Potential Drug Targets for the Treatment of Schizophrenia, Drug Abuse, and Parkinson’s DiseaseACS Chemical Neuroscience, 2011
- Discovery and optimization of a novel, selective and brain penetrant M1 positive allosteric modulator (PAM): The development of ML169, an MLPCN probeBioorganic & Medicinal Chemistry Letters, 2011
- Chemical lead optimization of a pan Gq mAChR M1, M3, M5 positive allosteric modulator (PAM) lead. Part II: Development of a potent and highly selective M1 PAMBioorganic & Medicinal Chemistry Letters, 2010
- Molecular Mechanisms of Action and In Vivo Validation of an M4 Muscarinic Acetylcholine Receptor Allosteric Modulator with Potential Antipsychotic PropertiesNeuropsychopharmacology, 2009
- Chemical lead optimization of a pan Gq mAChR M1, M3, M5 positive allosteric modulator (PAM) lead. Part I: Development of the first highly selective M5 PAMBioorganic & Medicinal Chemistry Letters, 2009
- Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disordersTrends in Pharmacological Sciences, 2009
- How many drug targets are there?Nature Reviews Drug Discovery, 2006